Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Gene Therapy|March 20, 2012
Viral and non-viral methods to genetically modify dendritic cellsJean-Marc Humbert, Franck Halary
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 9, 2019
Intra-patient viral evolution in polyomavirus-related diseasesDorian McIlroy, Franck Halary, Céline Bressollette-Bodin
Frontiers in Bioengineering and Biotechnology|August 8, 2022
The degradation of gelatin/alginate/fibrin hydrogels is cell type dependent and can be modulated by targeting fibrinolysisElea Boucard, Luciano Vidal, Flora Coulon, et al.
The Journal of Experimental Medicine|February 6, 2002
+1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10Xavier Saulquin, Emmanuel Scotet, Lydie Trautmann, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|February 28, 2025
A perfused iPSC-derived proximal tubule model for predicting drug-induced kidney injuryMichelle Lechtenberg, Coraline Chéneau, Kevin Riquin, et al.
Essays in Biochemistry|June 7, 2021
Bioprinting of kidney in vitro models: cells, biomaterials, and manufacturing techniquesMaaike F J Fransen, Gabriele Addario, Carlijn V C Bouten, et al.
Plos One|April 13, 2012
Human cytomegalovirus entry into dendritic cells occurs via a macropinocytosis-like pathway in a pH-independent and cholesterol-dependent mannerFabienne Haspot, Amélie Lavault, Christian Sinzger, et al.
European Journal of Immunology|May 3, 2005
Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of gammadelta T cellsXavier Lafarge, Vincent Pitard, Sophie Ravet, et al.
Immunity|November 16, 2002
Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infectionFranck Halary, Ali Amara, Hugues Lortat-Jacob, et al.
The Journal of Experimental Medicine|May 18, 2005
Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cellsFranck Halary, Vincent Pitard, Dorota Dlubek, et al.
Pageof 3